Skip to main content
. 2017 Oct 22;50(1):127–135. doi: 10.1007/s11255-017-1729-1

Fig. 1.

Fig. 1

The levels of AA in control group and CKD group (a) and comparison of the levels of AA among the patients with the different stage of CKD (b). *,**,*** P values respectively < 0.05; < 0.01; < 0.001; (controls vs. others). ^,^^,^^^ P values respectively < 0.05; < 0.01; < 0.001; (severe to end-stage CKD vs. mild to moderate CKD). AA, anthranilic acid; CKD, chronic kidney disease